Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2014

01-06-2014 | Original Article

Rate of Seroconversion in Repeat Blood Donors at The National Blood Centre, Kuala Lumpur

Authors: A. Nafishah, M. Nor Asiah, A. T. Nur Syimah, T. H. Mohd Zahari, A. Yasmin, M. Normi, E. Anza, M. Shahnaz, M. Y. Narazah

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2014

Login to get access

Abstract

The World Health Organization (WHO) recommend that all donated blood are to be screened for at least three viral infections [human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV)]. The National Blood Centre, Kuala Lumpur (NBCKL) aims to reduce transfusion transmitted infections (TTI) as it still remains as one of the major risk for blood transfusion. A cross sectional study was conducted at the National Blood Centre, Kuala Lumpur from 1st January 2009 to 31st June 2010. Data from 581,020 donors were analyzed from year 2004 to 2008. All data were retrieved from NBCKL Blood Bank Information System (BBIS). A total of 201 repeat donors were included in the study based on the inclusion criteria but only 132 repeat donors agreed to participate. Information on sociodemographic, risk factors, knowledge of donors and high risk behavior were extracted from standardize questionnaire. Data were analyzed using SPSS version 14.0. The aim of this study was to determine the predictors of the seropositive infectivity among repeat blood donors at the NBCKL. The results showed Syphilis accounts for the highest and increasing seroconversion rate among other infections from 20.83 % in year 2004 to 44.6 % in year in year 2008. HIV and HCV infection also showed increasing seroconversion rate in 5 years’ time from 6.41 % in year 2004 to 17.54 % in year 2008 and 4.8 % in year 2004 to 5.94 % in year 2008 respectively. However, HBV infection alone showed a decreasing seroconversion rate from 20.83 % in year 2004 to 10.4 % in year 2008. Level of donors’ awareness regarding high risk factors (activities or behaviour) can lead to higher risk of TTI with significant p value in this predictors model(p < 0.05). Repeat blood donors with high risk activities are more likely to have seropositive results for HBV, HIV and Syphilis. This study found that the frequency of HCV seropositivity is higher among lapsed donor. Socio demographic factors such as male and working in the private sector predominates in all TTI markers. Majority of the respondents were aware about relation of high risk activities and risk of TTI.
Literature
1.
go back to reference Klein HG (1995) Allogenic transfusion risk in the surgical patients. AMJ Surg 170:21–26CrossRef Klein HG (1995) Allogenic transfusion risk in the surgical patients. AMJ Surg 170:21–26CrossRef
2.
go back to reference Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685–1690PubMedCrossRef Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ (1996) The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334:1685–1690PubMedCrossRef
3.
go back to reference Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP (2003) Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 43:696–704PubMedCrossRef Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP (2003) Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 43:696–704PubMedCrossRef
4.
go back to reference Murray P, Rosenthal K, Kobayashi G, Pfaller M (2002) Medical Microbiology. Mosby company, St Loius 4:379–380 Murray P, Rosenthal K, Kobayashi G, Pfaller M (2002) Medical Microbiology. Mosby company, St Loius 4:379–380
5.
go back to reference Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S et al (2003) Incidence and estimated rates of residual risk for HIV, hepatits C, Hepatits B, and Human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000. Can Med Assoc J 168(8):767–773 Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S et al (2003) Incidence and estimated rates of residual risk for HIV, hepatits C, Hepatits B, and Human T-cell lymphotropic viruses in blood donors in Canada, 1990–2000. Can Med Assoc J 168(8):767–773
6.
go back to reference Sl Stramer, Glynn SA, Kleinman SH, Strong M, Caglioti S et al (2004) Detection of HIV-1 and HCV infection among antibody negative blood donors by nucleic acid-amplification testing. N Eng J Med 351:760–768CrossRef Sl Stramer, Glynn SA, Kleinman SH, Strong M, Caglioti S et al (2004) Detection of HIV-1 and HCV infection among antibody negative blood donors by nucleic acid-amplification testing. N Eng J Med 351:760–768CrossRef
7.
go back to reference Thomson RA, Bethel J, Ay Lo et al (1998) Retention of “safe” blood donors. Transfusion 38:6–359CrossRef Thomson RA, Bethel J, Ay Lo et al (1998) Retention of “safe” blood donors. Transfusion 38:6–359CrossRef
8.
go back to reference Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO et al (1996) Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691–1696PubMedCrossRef Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO et al (1996) Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 334:1691–1696PubMedCrossRef
9.
go back to reference Lewis-Ximenez JL, do OKMR, Ginuino CF, Silva JC, Schatzman HG et al (2002) Risk factors for Hepatitis B virus infection in Rio de Jeneiro Brazil. BMC Public Health 2:26PubMedCentralPubMedCrossRef Lewis-Ximenez JL, do OKMR, Ginuino CF, Silva JC, Schatzman HG et al (2002) Risk factors for Hepatitis B virus infection in Rio de Jeneiro Brazil. BMC Public Health 2:26PubMedCentralPubMedCrossRef
10.
go back to reference Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M (2004) Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 35(1):147–154PubMed Luksamijarulkul P, Thammata N, Sujirarat D, Tiloklurs M (2004) Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form. Southeast Asian J Trop Med Public Health 35(1):147–154PubMed
11.
go back to reference Singh B, Verma M, Kotru M, Verma K, Batra M (2005) Prevalence of HIV and VDRL seropositivity in blood donors of Delhi. Indian J Med Res 122:234PubMed Singh B, Verma M, Kotru M, Verma K, Batra M (2005) Prevalence of HIV and VDRL seropositivity in blood donors of Delhi. Indian J Med Res 122:234PubMed
12.
go back to reference Musto JA, Seed CR, Law M, Keller AJ, Kaldor JM (2000) Estimating the risk of blood donation associated with HIV risk behaviours. Transfus Medicine 18:49–54CrossRef Musto JA, Seed CR, Law M, Keller AJ, Kaldor JM (2000) Estimating the risk of blood donation associated with HIV risk behaviours. Transfus Medicine 18:49–54CrossRef
13.
go back to reference Glynn SA, Kleinman SH, Shcreiber GB, Busch MP, Wright DJ et al (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991–1996. J Am Medicine Assoc (JAMA) 284:229–235CrossRef Glynn SA, Kleinman SH, Shcreiber GB, Busch MP, Wright DJ et al (2000) Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991–1996. J Am Medicine Assoc (JAMA) 284:229–235CrossRef
14.
go back to reference Van der Poel CL, Seifried E, Schaasberg WP (2002) Paying for blood donation: still a risk? Vox Sang 83(4):285–293PubMedCrossRef Van der Poel CL, Seifried E, Schaasberg WP (2002) Paying for blood donation: still a risk? Vox Sang 83(4):285–293PubMedCrossRef
15.
16.
go back to reference Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A et al (2010) Seroprevalence of HIV, HBV, HCV and syphilis infectious among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia; declining trends over a period of five years. BMC Infect Dis 10:11CrossRef Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A et al (2010) Seroprevalence of HIV, HBV, HCV and syphilis infectious among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia; declining trends over a period of five years. BMC Infect Dis 10:11CrossRef
17.
go back to reference Jutavijittum P, Yousukh A, Samountry B, Samountry K, Ounavong A et al (2007) Seroprevalence of Hepatitis B and C virus infections among Lao blood donors. Southeast Asian J Trop Med Public Health 38(4):674–679PubMed Jutavijittum P, Yousukh A, Samountry B, Samountry K, Ounavong A et al (2007) Seroprevalence of Hepatitis B and C virus infections among Lao blood donors. Southeast Asian J Trop Med Public Health 38(4):674–679PubMed
18.
go back to reference Promwong C. Prevalence of seroconversion among various blood donors group in Blood Bank Songklanagarind Hospital. Poster presentation in 16th Annually Academic Meeting of Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. 16–18 Aug 2000 Promwong C. Prevalence of seroconversion among various blood donors group in Blood Bank Songklanagarind Hospital. Poster presentation in 16th Annually Academic Meeting of Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand. 16–18 Aug 2000
19.
go back to reference Zachariah R, Harries AD, Nkhoma W, Arendt V, Spielman MP et al (2000) HIV prevalence and demographic risk factors in blood donors. EastAfrican Medi J 79(20):88–91 Zachariah R, Harries AD, Nkhoma W, Arendt V, Spielman MP et al (2000) HIV prevalence and demographic risk factors in blood donors. EastAfrican Medi J 79(20):88–91
Metadata
Title
Rate of Seroconversion in Repeat Blood Donors at The National Blood Centre, Kuala Lumpur
Authors
A. Nafishah
M. Nor Asiah
A. T. Nur Syimah
T. H. Mohd Zahari
A. Yasmin
M. Normi
E. Anza
M. Shahnaz
M. Y. Narazah
Publication date
01-06-2014
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2014
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-012-0213-4

Other articles of this Issue 2/2014

Indian Journal of Hematology and Blood Transfusion 2/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine